Logo image of MRBK

MERIDIAN CORP (MRBK) Stock Fundamental Analysis

NASDAQ:MRBK - Nasdaq - US58958P1049 - Common Stock - Currency: USD

14.07  -0.08 (-0.57%)

After market: 14.07 0 (0%)

Fundamental Rating

4

Taking everything into account, MRBK scores 4 out of 10 in our fundamental rating. MRBK was compared to 396 industry peers in the Banks industry. MRBK has a bad profitability rating. Also its financial health evaluation is rather negative. MRBK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MRBK had positive earnings in the past year.
MRBK had a positive operating cash flow in the past year.
Each year in the past 5 years MRBK has been profitable.
MRBK had a positive operating cash flow in 4 of the past 5 years.
MRBK Yearly Net Income VS EBIT VS OCF VS FCFMRBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of MRBK (0.69%) is worse than 61.62% of its industry peers.
The Return On Equity of MRBK (9.53%) is better than 63.13% of its industry peers.
Industry RankSector Rank
ROA 0.69%
ROE 9.53%
ROIC N/A
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
MRBK Yearly ROA, ROE, ROICMRBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

MRBK's Profit Margin of 14.55% is on the low side compared to the rest of the industry. MRBK is outperformed by 76.77% of its industry peers.
MRBK's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for MRBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 14.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
MRBK Yearly Profit, Operating, Gross MarginsMRBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

MRBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRBK has been increased compared to 1 year ago.
MRBK has less shares outstanding than it did 5 years ago.
MRBK has a better debt/assets ratio than last year.
MRBK Yearly Shares OutstandingMRBK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MRBK Yearly Total Debt VS Total AssetsMRBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRBK has a debt to FCF ratio of 19.29. This is a negative value and a sign of low solvency as MRBK would need 19.29 years to pay back of all of its debts.
The Debt to FCF ratio of MRBK (19.29) is worse than 82.32% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that MRBK has dependencies on debt financing.
The Debt to Equity ratio of MRBK (1.02) is worse than 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 19.29
Altman-Z N/A
ROIC/WACCN/A
WACC23.82%
MRBK Yearly LT Debt VS Equity VS FCFMRBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MRBK Yearly Current Assets VS Current LiabilitesMRBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

MRBK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.52%, which is quite good.
The Earnings Per Share has been decreasing by -6.10% on average over the past years.
The Revenue has grown by 11.33% in the past year. This is quite good.
MRBK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.11% yearly.
EPS 1Y (TTM)9.52%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%10.19%

3.2 Future

The Earnings Per Share is expected to grow by 34.80% on average over the next years. This is a very strong growth
MRBK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.04% yearly.
EPS Next Y30.71%
EPS Next 2Y34.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.51%
Revenue Next 2Y11.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MRBK Yearly Revenue VS EstimatesMRBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MRBK Yearly EPS VS EstimatesMRBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.23, which indicates a correct valuation of MRBK.
MRBK's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.70, MRBK is valued rather cheaply.
MRBK is valuated cheaply with a Price/Forward Earnings ratio of 6.51.
92.17% of the companies in the same industry are more expensive than MRBK, based on the Price/Forward Earnings ratio.
MRBK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.49.
Industry RankSector Rank
PE 12.23
Fwd PE 6.51
MRBK Price Earnings VS Forward Price EarningsMRBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MRBK is valued a bit more expensive than the industry average as 69.44% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 17.59
EV/EBITDA N/A
MRBK Per share dataMRBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRBK's earnings are expected to grow with 34.80% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y34.8%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MRBK has a Yearly Dividend Yield of 3.47%.
MRBK's Dividend Yield is a higher than the industry average which is at 3.34.
Compared to an average S&P500 Dividend Yield of 2.36, MRBK pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.47%

5.2 History

MRBK has been paying a dividend for over 5 years, so it has already some track record.
MRBK has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
MRBK Yearly Dividends per shareMRBK Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

MRBK pays out 34.27% of its income as dividend. This is a sustainable payout ratio.
DP34.27%
EPS Next 2Y34.8%
EPS Next 3YN/A
MRBK Yearly Income VS Free CF VS DividendMRBK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
MRBK Dividend Payout.MRBK Dividend Payout, showing the Payout Ratio.MRBK Dividend Payout.PayoutRetained Earnings

MERIDIAN CORP

NASDAQ:MRBK (5/19/2025, 8:00:02 PM)

After market: 14.07 0 (0%)

14.07

-0.08 (-0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-25 2025-04-25/dmh
Earnings (Next)07-24 2025-07-24
Inst Owners61.6%
Inst Owner Change0.96%
Ins Owners9.63%
Ins Owner Change0.98%
Market Cap158.85M
Analysts80
Price Target17.34 (23.24%)
Short Float %0.49%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield 3.47%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP34.27%
Div Incr Years0
Div Non Decr Years1
Ex-Date05-12 2025-05-12 (0.125)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.52%
Min EPS beat(2)-32.69%
Max EPS beat(2)17.65%
EPS beat(4)1
Avg EPS beat(4)-5.99%
Min EPS beat(4)-32.69%
Max EPS beat(4)17.65%
EPS beat(8)3
Avg EPS beat(8)-13.43%
EPS beat(12)5
Avg EPS beat(12)-8.8%
EPS beat(16)9
Avg EPS beat(16)0.51%
Revenue beat(2)2
Avg Revenue beat(2)5.63%
Min Revenue beat(2)3.87%
Max Revenue beat(2)7.39%
Revenue beat(4)3
Avg Revenue beat(4)2.84%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)7.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.77%
Revenue beat(12)4
Avg Revenue beat(12)-2.53%
Revenue beat(16)8
Avg Revenue beat(16)0.89%
PT rev (1m)-5.56%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-11.34%
EPS NY rev (3m)-11.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 12.23
Fwd PE 6.51
P/S 1.41
P/FCF 17.59
P/OCF 16.55
P/B 0.93
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)1.15
EY8.17%
EPS(NY)2.16
Fwd EY15.37%
FCF(TTM)0.8
FCFY5.68%
OCF(TTM)0.85
OCFY6.04%
SpS9.95
BVpS15.19
TBVpS14.48
PEG (NY)0.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 9.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.55%
GM N/A
FCFM 8.04%
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 19.29
Debt/EBITDA N/A
Cap/Depr 24.71%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 55.24%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC23.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.8%
Profit Quality(3y)186.36%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.52%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%-16.67%
EPS Next Y30.71%
EPS Next 2Y34.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.33%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%10.19%
Revenue Next Year11.51%
Revenue Next 2Y11.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.98%
FCF growth 3Y-61.62%
FCF growth 5Y-15.45%
OCF growth 1Y-49.1%
OCF growth 3Y-61.26%
OCF growth 5Y-14.98%